Early-stage cancer treatment in the context of molecular imaging (Q2888639): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Created claim: summary (P836): This project aims to focus on two lines of research, which are directly related to each other, (i) the diagnosis and (ii) the treatment of early-stage cancers which, through prospective clinical trials, will be able, on the one hand, to test new diagnostic technologies with greater precision, and, on the other, to demonstrate which treatment is most appropriate, most effective and at the lowest cost associated., translated_summary)
(‎Removed claim: co-financing rate (P837): 79.0 percent, Removing co-finance rate from projects in portugal)
Property / co-financing rate
79.0 percent
Amount79.0 percent
Unitpercent
 
Property / co-financing rate: 79.0 percent / rank
Normal rank
 

Revision as of 13:11, 13 September 2021

Project Q2888639 in Portugal
Language Label Description Also known as
English
Early-stage cancer treatment in the context of molecular imaging
Project Q2888639 in Portugal

    Statements

    0 references
    2,454,184.2 Euro
    0 references
    31 March 2016
    0 references
    28 June 2020
    0 references
    INSTITUTO PORTUGUÊS DE ONCOLOGIA DO PORTO FRANCISCO GENTIL - E.P.E.
    0 references
    Q2997125 (Deleted Item)
    0 references

    41°10'26.22"N, 8°36'20.95"W
    0 references
    O presente projeto pretende focar-se em duas linhas de investigação, diretamente relacionadas entre si, (i) o diagnóstico e (ii) o tratamento de cancros em fase inicial que, através de ensaios clínicos prospetivos, consigam, por um lado, testar novas tecnologias de diagnóstico, com maior precisão, e, por outro, demonstrar qual o tratamento mais adequado, mais eficaz e com menor custo associado. (Portuguese)
    0 references
    This project aims to focus on two lines of research, which are directly related to each other, (i) the diagnosis and (ii) the treatment of early-stage cancers which, through prospective clinical trials, will be able, on the one hand, to test new diagnostic technologies with greater precision, and, on the other, to demonstrate which treatment is most appropriate, most effective and at the lowest cost associated. (English)
    8 July 2021
    0 references
    Porto, Paranhos
    0 references

    Identifiers

    NORTE-01-0145-FEDER-000027
    0 references